Biodexa Announces Recruitment of First Patient in Phase 2 Study of Tolimidone in Type 1 Diabetes Biodexa Pharmaceuticals PLC ...

Original-Research: Sernova Biotherapeutics Inc - from First Berlin Equity Research GmbH02.06.2025 / 13:39 CET/CESTDissemination of a Research, transmitted by EQS News - a service of EQS Group.The ...

You have a history of severe fluctuations in blood sugar You have type I diabetes, which is confirmed with a C-peptide level lower than 0.5, and have used an insulin pump before enrolling in ...

Growth Hormone-Releasing Peptide-2 (GHRP-2) is a synthetic hexapeptide that has garnered significant attention in the ...

Mounjaro is the brand name for tirzepatide, a prescription medication developed by Eli Lilly that is primarily used to treat ...

TUCSON, AZ / ACCESS Newswire / June 2, 2025 / Umbrella Labs, a leading supplier of advanced research chemicals, announced the expansion of its peptide catalog to include Retatrutide (LY3437943), an ...

Sure, I wee like Austin Powers and the number twos are like tennis balls – get comfortable with that idea. But I’m the best ...

The company’s strategic moves—acquiring a peptide facility ... they are proteins. They include insulin and GLP-1 analogues such as semaglutide. They play a central role in biological function ...

A study of real-world and virtual patients suggests that a less frequent dosing of glucagon-like peptide 1 receptor agonists ...

Highlights from the 2025 Global Equine Endocrinology Symposium included never-before-presented study results on insulin ...

Identifying proteomic signatures of insulin resistance in fasting muscle offers insights for personalized type 2 diabetes ...

This study presents compelling evidence that the denitrosylase SCoR2 regulates cardioprotective metabolic reprogramming in the heart following ischemia/reperfusion injury. The findings are supported ...